mRNA INDUCED SPIKE PROTEIN FOUND IN CEREBRAL ARTERIES OF STROKE PATIENTS IN NEW STUDY...
This is the first peer-reviewed study to document persistent spike expression in cerebral vasculature more than a year after mRNA vaccination, directly associating it with hemorrhagic stroke cases.
Japanese neurosurgeons and pathologists analyzed 19 cases of hemorrhagic stroke at Sapporo Teishinkai Hospital (March 2023–April 2024). Researchers assessed whether the SARS-CoV-2 spike protein, introduced via mRNA vaccination, persists in cerebral tissues.
SPIKE PROTEIN WAS DETECTED IN THE CEREBRAL ARTERIES OF 43.8% OF THE VACCINATED INDIVIDUALS, UP TO 17 POST INJECTION.
In situ hybridization in three patients confirmed the presence of both vaccine-derived mRNA and spike-encoding viral RNA in brain vasculature, though without conclusive proof of which source dominated.
Notably, all spike-positive cases were female—a statistically significant finding (p = 0.015), raising questions about sex-based susceptibility to spike persistence or associated vascular events.
THESE FINDINGS DISTURB ASSUMPTIONS ABOUT VACCINE BIODISTRIBUTION.
While lipid nanoparticles were expected to degrade rapidly, evidence here suggests long-term vascular retention and protein expression within critical tissues.
